Organon Corp (OGN) - Multiplikator Forward P/S

Logo perusahaan publik Organon (OGN)

Organon & Co. (OGN) relies on a global network of plants and unique patents in the women's health sector. The scalable business of this Merck spin-off serves as a cash cow, generating strong cash flow through low-cost contraceptive production. The projected P/S trend captures the objective value of the assets, where the indicator stands at 0.10. Risks are linked to the debt load and dependence on sales of a key implant.

Organon - Multiplikator Forward P/S OGN (periode 04.07.2022 - 13.11.2026)

OGN (Organon Pharma): rincian analitis lan laporan miturut indikator

- rega pasar lan target rega analis:
Bagan rega Organon|OGN - Konsensus nilai wajar
- indikator kapitalisasi pasar:
Kapitalisasi pasar Organon Pharma|OGN - Nilai Perusahaan Nalika Diakuisisi Penuh
- statistik nilai buku emiten:
Nilai Buku saben Saham Organon|OGN - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku organon.com|OGN - Total Aset Bisnis
- rincian utang lan likuiditas:
Utang marang Ekuitas Organon & Co.|OGN - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Organon & Co.|OGN - Utang agregat perusahaan|Utang marang nilai buku Organon Pharma|OGN - Silihan lan utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Organon|Indikator likuiditas cepet organon.com
- rincian asil keuangan lan kelipatan valuasi:
OGN - Bathi pungkasan|Proyeksi bathi mangsa ngarep Organon & Co.|OGN - Koefisien rega marang bathi|Rega marang bathi mangsa ngarep Organon Corp|OGN - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Organon Pharma|OGN - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Organon|OGN - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan organon.com|OGN - Owah-owahan bathi resik saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Organon & Co.
- data total pendapatan lan volume dodolan:
OGN - Volume dodolan perusahaan|Prakiraan pendapatan perusahaan Organon|OGN - Rasio rega marang dodolan|Multiplikator Forward P/S Organon Pharma
Pambiji fundamental perusahaan:Organon (OGN)
Produk asli Organon & Co.

Stable sales of biosimilars and women's health products from Organon & Co. (OGN) create a revenue foundation that the market values while accounting for patent risks. The forward P/S metric correlates current market capitalization with projected sales volume, allowing investors to determine the degree of business undervaluation and identify phases of hidden accumulation or asset liquidation through the analysis of this curve.

Pesaing wigati

Rasio rega marang prakiraan pendapatan Daré Bioscience DARE|Rega forward marang dodolan TXMD|Palatin - Multiplikator Forward P/S